The South Korea Radiopharmaceuticals Market Segment is primarily divided into diagnostic and therapeutic applications, with diagnostics currently holding a larger market share. The diagnostic segment is a cornerstone of the market, driven by the widespread use of isotopes like Technetium-99m in PET and SPECT scans for early detection and monitoring of various diseases. This segment is bolstered...